Air pollution associated with cancer mortality beyond lung cancer

November 1, 2017, Barcelona Institute for Global Health

Air pollution is classified as carcinogenic to humans given its association with lung cancer, but there is little evidence for its association with cancer at other body sites. In a new large-scale prospective study led by the Barcelona Institute of Global Health (ISGlobal), researchers observed an association between certain air pollutants and mortality from kidney, bladder and colorectal cancer.

The study, published in Environmental Health Perspectives, included more than 600,000 adults in the U.S. who participated in the Cancer Prevention Study II and who were followed for 22 years (from 1982 to 2004). The researchers examined associations of mortality from cancer at 29 sites with long-term residential exposure to three ambient pollutants: PM2,5, nitrogen dioxide (NO2) and ozone (O3).

Over 43,000 non-lung cancer deaths were registered among the participants. PM2,5 was associated with mortality from kidney and bladder cancer, with a 14 and 13 percent increase, respectively, for each 4.4 μg/m3 increase in exposure. In turn, exposure to NO2 was associated with death, with a 6 percent increase per each 6.5 ppb increment. No significant associations were observed with cancer at other sites.

Michelle Turner, ISGlobal researcher and first author of the study, says, "Although a number of studies associate with air pollution, there is still little evidence for associations at other cancer sites. This research suggests that was not associated with death from most non-lung cancers, but the associations with kidney, bladder and colorectal deserve further investigation."

Explore further: Study indicates arsenic can cause cancer decades after exposure ends

More information: Michelle C. Turner et al, Ambient Air Pollution and Cancer Mortality in the Cancer Prevention Study II, Environmental Health Perspectives (2017). DOI: 10.1289/EHP1249

Related Stories

Study indicates arsenic can cause cancer decades after exposure ends

October 24, 2017
A new paper published in the Journal of the National Cancer Institute shows that arsenic in drinking water may have one of the longest dormancy periods of any carcinogen. By tracking the mortality rates of people exposed ...

Heart failure is as 'malignant' as some common cancers

May 4, 2017
A new analysis finds that, despite advances in care, men and women with a diagnosis of heart failure continue to have worse survival rates than patients with certain common cancers.

Exposure to particulate air pollutants associated with numerous cancers

April 29, 2016
Researchers have found that long-term exposure to environmental pollutants was associated with increased risk of mortality for many types of cancer in an elderly Hong Kong population.

Smoking linked to higher risk of death among colorectal cancer survivors

February 3, 2015
Colorectal cancer survivors who smoke cigarettes were at more than twice the risk of death than non-smoking survivors, adding to existing evidence that cigarette smoking is associated with higher all-cause and colorectal ...

Second, unrelated malignancies strike 1 in 12 cancer patients

July 11, 2016
(HealthDay)—A new study indicates that 8 percent of patients—or one in 12—already diagnosed with one form of cancer will develop a second unrelated malignancy. The findings were published online July 5 in Cancer.

Smoking associated with elevated risk of developing a second smoking-related cancer

November 10, 2014
Results of a federally-funded pooled analysis of five prospective cohort studies indicate that cigarette smoking prior to the first diagnosis of lung (stage I), bladder, kidney or head and neck cancer increases risk of developing ...

Recommended for you

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

An integrated approach to finding new treatments for breast cancer

December 12, 2018
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And proteogenomics, an integrated, multipronged approach, seems ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.